A Phase IIIb, 24-week, Randomised, Placebo-controlled, Double-blinded, Efficacy and Safety Study of Linagliptin (BI 1356) in Black/African American Patients With Type 2 Diabetes With a MTT Sub-study
收藏DataCite Commons2025-12-08 更新2026-05-07 收录
下载链接：
https://search.vivli.org/doiLanding/studies/00003618/isLanding
下载链接
链接失效反馈官方服务：
资源简介：
Study of linagliptin vs. placebo in Black/African American patients with T2DM with a MTT sub-study
提供机构：
Vivli
创建时间：
2019-04-12
